2024-08 An Evidence-Based Approach to Treating T2D in Adults

2024 VAPHS Live NP Training

August 29 2024

excellent speaker w respect to updated and complicated pharmacology

Very informative. Thank you!

The objective were good

I learnt a lot of current and new information. Thank you
— Kudos for Dr. Weart August 2024
  1. Describe the 2024 American Diabetes Association Standards of Care for Patients with Diabetes and the evidence on which they are based.

  2. Apply the results of landmark diabetes trials that established improved glycemic control reduces the risk of diabetes-related complications in patients with T2D

  3. Apply the evolving paradigm by which the treatment of T2D (A1C reduction) has shifted to an outcome-based approach focused on risk reduction, particularly in older patients with established CVD, HF, CKD and/or Obesity.

About This Course

This on demand course was recorded live in a zoom training course for the VAPHS. It provides 1 hours. live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/ CME credit.

Price $19 for 1 Hours

Purchase 2024-08 An Evidence-Based Approach to Treating T2D in Adults

Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP

Professor Emeritus of Family Medicine, Department of Family Medicine, Medical University of South Carolina, Professor Emeritus of Clinical Pharmacy & Outcome Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.

Learn More

TARGET AUDIENCE/ ACCREDITATION

PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.

NURSE PRACTITIONERS/ NURSES: This course provides 10 contact hours (1.0CEU) to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours  for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .

PHYSICIANS: The AAFP has reviewed Providing Better Patient Care June 10-12, 2025 and deemed it acceptable for up to 10.00 AAFP Prescribed credit(s). Term of Approval is from 06/10/2025 to 06/12/2028. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award.  When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. 

CME programs approved by the AAFP are eligible for Category 2 credit  (or Category 1-A  under special circumstances) through the American Osteopathic Association (AOA).

PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.

CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).  This credit is applicable to health professionals who may require pharmacology credit.

CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 10 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.

OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.